MLB’s civil case against Biogenesis and others is still proceeding. One of the others is interesting.

38 Comments

Part of MLB’s deal with Anthony Bosch is that the league will dismiss the lawsuit it filed against him. It hasn’t done that yet. Which isn’t terribly surprising as MLB is still probably wanting to ensure continued cooperation from him and to ensure that they get something of value from him. The court likely won’t make the league do anything until various deadlines approach that require its attention.

But there are other defendants besides Bosch. One of them is his former colleague who is alleged by MLB to have also given players PEDs. His name is Carlos Acevedo and just this afternoon his latest request to have the lawsuit against him dismissed was denied, so he’s still in MLB’s crosshairs.

Acevedo is an interesting character here. I presume his defense — in addition to some statute of limitations grounds mentioned in the linked article — will be that he had nothing to do with Biogenesis. Which may be technically true. However, Acevedo and Bosch were partners in a predecessor anti-aging clinic before they had a falling out and went their separate ways. And it wasn’t too terribly long ago that this happened. The third partner in that clinic, a guy named Xavier Romero, left with Acevedo. He told the New York Times a couple of months ago that (a) he didn’t do anything with athletes; and (b) Bosch was a wreck and that he was surprised that he’d be able to lure baseball players as clients. The article also noted that Acevedo had a good reputation in the anti-aging community and worked with solid medical companies in the past.

Which makes me wonder about Major League Baseball’s interest in Acevedo. Do they think that he was a source of PEDs to players? If so, you’d think he’d be a better target for cooperation than Bosch, given his apparently more august standing in the world, his greater ability (in Romano’s view, one presumes) to lure high profile clients; and, by extension, his fewer credibility problems. On the other hand, if they don’t think he was involved, this lawsuit, with respect to Acevedo anyway, stinks to high heavens.

While I disagreed with Major League Baseball’s lawsuit when it was filed and still believe it’s the weakest legal sauce imaginable, I don’t think MLB is in the business of harassing truly innocent parties, which is what they’d be doing here if Acevedo didn’t have some sort of involvement in providing drugs to players. Which makes me think that maybe they’re trying to do with Acevedo what they did with Bosch: flip him and get him to talk about players’ drug use. Which suggests that either MLB doesn’t think that it yet has the goods or that it’s being extremely deliberate as it builds its case.

If they do have the goods on the players, though, you’d think they’d quit pursuing Acevedo, right?

Report: Welington Castillo to be suspended 80 games for violating Joint Drug Agreement

David Banks/Getty Images
2 Comments

Ken Rosenthal of The Athletic confirms a report from journalist Américo Celado that White Sox catcher Welington Castillo will be suspended 80 games for violating baseball’s Joint Drug Agreement. Castillo was believed to have used a steroid, but according to Rosenthal, the substance was not a steroid. More details should come on Thursday.

Castillo, 31, entered Wednesday’s action batting .270/.314/.477 with six home runs and 15 RBI in 118 plate appearances. He has gotten the bulk of the work behind the plate, backed up by Omar Narváez.

Castillo’s absence will likely prompt the White Sox to call up Kevan Smith from Triple-A Charlotte. Smith battled an ankle injury in March and April, so he got a late start to the season. In 102 PA at Triple-A, he has hit .283/.343/.457.